INS and metabolic disease: Sustained improvements in adiponectin levels may enhance metabolic flexibility, improve insulin sensitivity, and potentially contribute to improved metabolic health, which is critical for preventing metabolic diseases such as type 2 diabetes and cardiovascular disorders.